Top in hematology/oncology: COVID-19 and PTSD

According to projections from the National Cancer Institute, COVID-19 will result in 10,000 additional deaths due to breast cancer and colorectal cancer over the next 10 years. This was the top story in hematology/oncology last week.

Another top story reported on new study results that show one-fifth of patients who have undergone hematopoietic stem cell transplantation developed symptoms of PTSD within 6 months.

Read these and more top stories below.

COVID-19 may lead to 10,000 excess deaths due to breast, colorectal cancers

The COVID-19 pandemic will result in nearly 10,000 additional deaths due to breast cancer and colorectal cancer over the next decade, according to NCI projections. Read more.

Many patients develop clinically significant PTSD symptoms early after HSCT

Nearly one-fifth of patients who undergo hematopoietic stem cell transplantation develop symptoms of PTSD within 6 months, according to study results presented during the ASCO20 Virtual Scientific Program. Read more.

Black patients less represented in pharmaceutical-led vs. NCI-sponsored cancer trials

Black patients with cancer have been significantly underrepresented in pharmaceutical company-sponsored clinical trials, according to study results presented at American Association for Cancer Research Virtual Annual Meeting II. Read more.

Treatment with immune checkpoint inhibitors may lead to more severe COVID-19 illness

Patients with cancer who contract COVID-19 may be at a higher risk for hospitalization and severe disease if they are undergoing treatment with immune checkpoint inhibitors, according to results of a retrospective study published in Nature Medicine. Read more.

Lipophilic statin use associated with reduced ovarian cancer mortality

Lipophilic statins appeared associated with reduced mortality among women with ovarian cancer, according to results of a retrospective study presented at American Association for Cancer Research Virtual Annual Meeting II. Read more.